C A Steward1, C A Marsden, M J W Prior, P G Morris, Y B Shah. 1. Institute of Neuroscience, Sir Peter Mansfield Magnetic Resonance Centre, University of Nottingham, University Park, Nottingham, NG7 2RD, UK. mbxcas@nottingham.ac.uk
Abstract
RATIONALE AND OBJECTIVES: Blood oxygen level dependent (BOLD) contrast pharmacological magnetic resonance imaging (phMRI) is an increasingly popular technique that allows the non-invasive investigation of spatial and temporal changes in rat brain function in response to pharmacological stimulation in vivo. Rat brain BOLD contrast phMRI is, at present, established in few neuropharmacological laboratories, and various issues associated with the technique require attention. The present review is primarily aimed at psychopharmacologists with no previous experience of phMRI, who are interested in the practical aspects that phMRI studies entail. RESULTS AND DISCUSSION: Experimental and analytical considerations, including anaesthesia, physiological monitoring, drug dose and delivery, scanning protocols, statistical approaches and the interpretation of phMRI data, are discussed.
RATIONALE AND OBJECTIVES: Blood oxygen level dependent (BOLD) contrast pharmacological magnetic resonance imaging (phMRI) is an increasingly popular technique that allows the non-invasive investigation of spatial and temporal changes in rat brain function in response to pharmacological stimulation in vivo. Rat brain BOLD contrast phMRI is, at present, established in few neuropharmacological laboratories, and various issues associated with the technique require attention. The present review is primarily aimed at psychopharmacologists with no previous experience of phMRI, who are interested in the practical aspects that phMRI studies entail. RESULTS AND DISCUSSION: Experimental and analytical considerations, including anaesthesia, physiological monitoring, drug dose and delivery, scanning protocols, statistical approaches and the interpretation of phMRI data, are discussed.
Authors: F Di Salle; F Esposito; A Elefante; T Scarabino; A Volpicelli; S Cirillo; R Elefante; E Seifritz Journal: Eur J Radiol Date: 2003-11 Impact factor: 3.528
Authors: Petra Schweinhardt; Peter Fransson; Lars Olson; Christian Spenger; Jesper L R Andersson Journal: J Neurosci Methods Date: 2003-10-30 Impact factor: 2.390
Authors: Sergey Shcherbinin; Orla Doyle; Fernando O Zelaya; Sara de Simoni; Mitul A Mehta; Adam J Schwarz Journal: Psychopharmacology (Berl) Date: 2015-07-31 Impact factor: 4.530
Authors: Liming Luan; Feng Ding; Yi Ai; Anders Andersen; Peter Hardy; Eric Forman; Greg A Gerhardt; Don M Gash; Richard Grondin; Zhiming Zhang Journal: Cell Transplant Date: 2008 Impact factor: 4.064
Authors: Seung-Schik Yoo; Jong-Hwan Lee; Heather O'Leary; Lawrence P Panych; Ferenc A Jolesz Journal: Int J Imaging Syst Technol Date: 2008-06-13 Impact factor: 2.000
Authors: Peter R Kufahl; Natalie A Peartree; Krista L Heintzelman; Maggie Chung; Janet L Neisewander Journal: Brain Res Date: 2014-10-22 Impact factor: 3.252
Authors: Neil Easton; Yasmene B Shah; Fiona H Marshall; Kevin C Fone; Charles A Marsden Journal: Psychopharmacology (Berl) Date: 2006-10-03 Impact factor: 4.530
Authors: Katherine N Hewitt; Yasmene B Shah; Malcolm J W Prior; Peter G Morris; Chris P Hollis; Kevin C F Fone; Charles A Marsden Journal: Psychopharmacology (Berl) Date: 2005-04-28 Impact factor: 4.530